ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: GlobeNewswire
PORTLAND, Maine, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, plans to conduct a conference call with investors on Friday, January 9, 2026 at 9:00 AM ET. The Company first announced a strategic change in focus in favor of the First Defense® product line and away from Re-Tain® on December 24, 2025. The Company will also discuss its unaudited topline sales results for the fourth quarter and full year ended December 31, 2025, which will be announced after the market closes on Thursday, January 8, 2026. Conference Calls:The Company is planning to host a conference call on Friday, January 9, 2026 at 9:00 AM ET to discuss its strategic shift to First Defense® and away from Re-Tain® as well as its 2025 unaudited topline sales results. Interested parties can access the conference call by dialing (844) 855-9502 (toll
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025GlobeNewswire
- ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® [Yahoo! Finance]Yahoo! Finance
ICCC
Sec Filings
- 1/8/26 - Form 8-K
- 12/29/25 - Form 8-K
- 12/4/25 - Form 4/A
- ICCC's page on the SEC website